Long COVID as a disease of accelerated biological aging: An opportunity to translate geroscience interventions It has been four years since long COVID—the protracted consequences that survivors of COVID-19 face—was first described. Yet, this entity continues to…

While #sirolimus is included in the list of drugs being studied for long COVID, there are no data or published results yet demonstrating its efficacy or safety for this indication

www.sciencedirect.com/science/arti...
#Sirolimus is an #mTORinhibitor with immunosuppressive activity,

Angelini taps Sovargen for epilepsy drug in $550m deal Angelini Pharma has licensed a preclinical-stage mTOR inhibitor from South Korean biotech Sovargen with potential for genetic forms of epilepsy.

#AngeliniPharma has licensed a preclinical-stage #mTORinhibitor from South Korean biotech #Sovargen with potential for genetic forms of #epilepsy and other brain disorders.